114 related articles for article (PubMed ID: 3603815)
21. Relationship of estrogens and oral contraceptives to endometrial cancer in animals and women.
Drill VA
J Reprod Med; 1980 Jan; 24(1):5-13. PubMed ID: 6987399
[TBL] [Abstract][Full Text] [Related]
22. [Estrogen therapy for the climateric and thromboembolic risk].
Campagnoli C; Prelato L; Rossetti MG
Minerva Ginecol; 1980 May; 32(5):429-35. PubMed ID: 7393492
[TBL] [Abstract][Full Text] [Related]
23. [Oral contraceptives and hypertension].
Werning C; Siegenthaler W
Schweiz Med Wochenschr; 1971 Apr; 101(15):543-4. PubMed ID: 4325189
[TBL] [Abstract][Full Text] [Related]
24. [Rationale for prescribing oral contraceptives].
Teichmann AT
Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865
[TBL] [Abstract][Full Text] [Related]
25. The pills: oral contraceptives and other hormones.
Kome P
Homemak Mag; 1977 May; 12(4):33-4. PubMed ID: 12308626
[TBL] [Abstract][Full Text] [Related]
26. [Estrogens, progestins and blood lipids].
Tikkanen MJ
Duodecim; 1984; 100(22):1500-3. PubMed ID: 6518995
[TBL] [Abstract][Full Text] [Related]
27. Hypertension and oral contraception.
Smith RW
Trans Pac Coast Obstet Gynecol Soc; 1971; 39(0):50-5. PubMed ID: 5164822
[No Abstract] [Full Text] [Related]
28. Oral contraceptives.
Shearman RP
Aust Fam Physician; 1984 Sep; 13(9):685-91. PubMed ID: 6508652
[TBL] [Abstract][Full Text] [Related]
29. [Vasculorenal risks of oral contraceptives].
Kanfer A
Rev Prat; 1977 Apr; 27(23):1507-10. PubMed ID: 866957
[TBL] [Abstract][Full Text] [Related]
30. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
31. [Oral contraception: failures and risks].
Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
[TBL] [Abstract][Full Text] [Related]
32. [What do oral contraceptives do? What are oral contraceptives?].
Rignell S
Nord Med; 1971 Oct; 86(40):1168. PubMed ID: 5131957
[TBL] [Abstract][Full Text] [Related]
33. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
Gaspard U; Dubois M
Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
[TBL] [Abstract][Full Text] [Related]
34. [Hypertension and oral contraceptive therapy (author's transl)].
Colliard M; Einholtz V; Tcherdakoff P
Sem Hop; 1980 Sep 18-25; 56(33-36):1407-11. PubMed ID: 6252632
[TBL] [Abstract][Full Text] [Related]
35. [Combined estrogen-progestagen contraception and glucid and water-sodium metabolism].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1988 Feb; 16(2):3-7. PubMed ID: 12342001
[TBL] [Abstract][Full Text] [Related]
36. High blood pressure in women.
Calhoun DA; Oparil S
Int J Fertil Womens Med; 1997; 42(3):198-205. PubMed ID: 9222804
[TBL] [Abstract][Full Text] [Related]
37. [On the side effects of treatment with hormone preparations consisting of estrogen-gestagen combinations].
Osler M
Ugeskr Laeger; 1967 Mar; 129(9):294-6. PubMed ID: 5599492
[No Abstract] [Full Text] [Related]
38. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
Speroff L
Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
[TBL] [Abstract][Full Text] [Related]
39. Complications of systemic contraceptive agents: hypertension.
Wolfsen AR
West J Med; 1975 Jan; 122(1):38-40. PubMed ID: 1089005
[No Abstract] [Full Text] [Related]
40. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension.
Kawecka-Jaszcz K; Czarnecka D; Olszanecka A; Rajzer M; Jankowski P
J Hum Hypertens; 2002 Jul; 16(7):509-16. PubMed ID: 12080436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
